MCAD deficiency Nutritional, Metabolic, Endocrine
Conditions
Interventions
All participants undergo the two described study sessions as follows.
Incremental test on bicycle ergometer for determination of VO2max (session 1). Exercise for 80 minutes on bicycle ergometer and MR
Sponsors
University Medical Centre Groningen (Netherlands)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient group: Patients with MCAD deficiency who are over 18 years of age Control group: Healthy volunteers over 18 years of age, matched for age and gender to the patient group
Exclusion criteria
Exclusion criteria: 1. Disease other than MCAD deficiency 2. Contra-indications for MR analysis (e.g. the presence of metals in the body)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intramyocellular lipid content is measured by means of 1H-MRS. We obtain spectra at baseline and after prolonged exercise, and have professional help for analysis of the spectra. | — |
Secondary
| Measure | Time frame |
|---|---|
| Concentrations of phosphocreatine, adenosine 5?-triphosphate, inorganic phosphate, and intracellular pH. These are measured by 31P-MRS. We obtain spectra before, during, and after exercise, and have professional help for analysis of the spectra. | — |
Countries
Netherlands
Outcome results
None listed